La diapause embryonnaire se manifeste par un arrêt réversible du développement embryonnaire durant la période de préimplantation et induit un retard de l’implantation. Chez le vison américain, une diapause embryonnaire obligatoire caractérise chaque gestation. Si les mécanismes de contrôle de la diapause embryonnaire obligatoire chez cette espèce sont bien connus, le rôle utérin impliqué dans la réactivation de l’embryon demeure, quant à lui, encore inconnu. Le sujet de ce doctorat a consisté dans un premier temps à explorer l’environnement utérin à la sortie de la diapause embryonnaire afin de caractériser, dans un deuxième temps, les principaux acteurs utérins qui provoquent la réactivation de l’embryon. Nous avons effectué une analyse du transcriptome utérin à l’émergence de la diapause embryonnaire ce qui a permis de construire une librairie de 123 séquences d’ADNc utérines différentiellement exprimées à la réactivation de l’embryon et homologues à des séquences de gènes connues chez d’autres espèces. Ces gènes sont impliqués dans la régulation du métabolisme (25 %), de l’expression génique (21 %), de la transduction de signal (15 %), du cycle cellulaire (15 %), du transport (10 %) et de la structure cellulaire (9 %), reflétant ainsi d’importantes modifications utérines à la réactivation embryonnaire. Nous avons validé l’expression différentielle de dix gènes ainsi identifiés : GDF3 (growth and differentiation 3), ALCAM (activated leukocyte cell adhesion molecule), ADIPOR1 (adiponectin receptor 1), HMGN1 (high mobility group N1), TXNL1 (thioredoxin like 1), TGM2 (tissue transglutaminase 2), SPARC (secreted protein acidic rich in cystein), et trois gènes codant pour AZIN1 (antizyme inhibitor 1), ODC1 (ornithine decarboxylase 1) et SAT1 (spermidine/spermine N1-acetyltransferase), des enzymes impliquées dans la biosynthèse des polyamines. Le patron de l’expression spatio-temporel de SPARC et d’HMGN1 illustrent spécifiquement un remodelage tissulaire et de la chromatine au niveau utérin à la sortie de la diapause embryonnaire. Ayant mesuré une augmentation des concentrations utérines en polyamines à la reprise du développement embryonnaire, nous avons émis l’hypothèse que les polyamines seraient impliquées dans les événements menant à la sortie de la diapause. L’inhibition de la biosynthèse des polyamines par un traitement à l’ α-difluoromethylornithine (DFMO) a provoqué une diminution significative de la proliferation cellulaire dans les embryons à la réactivation, un retard du moment de l’implantation, mais n’a pas affecté le succès de la reproduction. De manière similaire, nous avons induit un état de dormance dans les cellules de trophoblaste de vison en présence DFMO dans le milieu de culture, et constaté que cet état était réversible. En conclusion, cette étude a non seulement ouvert de nouveaux horizons quant à la compréhension du rôle utérin dans les événements menant à la sortie de la diapause embryonnaire, mais a démontré pour la première fois, l’existence de facteurs utérins indispensables à la réactivation de l’embryon: les polyamines. / Embryonic diapause is characterized by a reversible arrest of blastocyst development prior to implantation and delay in implantation. In the American mink, embryonic diapause is a characteristic of each gestation. Although the mechanisms which control obligate embryonic diapause of this species are well known, the role of the uterus involved in blastocyst reactivation remains elusive. The subject of this doctoral research consisted first in exploring the uterine environment at the emergence of embryonic diapause in order to subsequently determine, the main factors in the uterus that provoke reactivation of the embryo. We have undertaken an analysis of the uterine transcriptome at the emergence of embryonic diapause which has enabled us to set up a library of 123 cDNA uterine sequences differentially expressed at blastocyst reactivation, and homologue gene sequences known in other species. Twenty-five percent of these genes are implicated in genetic expression, 15 % in cell signal transduction, 15 % in cell cycle, 10 % in transport and 9 % in cell structure. All of them reflect significant uterine modifications at blastocyst reactivation. We have validated differential expression of ten genes, identified as: GDF3 (growth and differentiation 3), ALCAM (activated leukocyte cell adhesion molecule), ADIPOR1 (adiponectin receptor 1), HMGN1 (high mobility group N1), TXNL1 (thioredoxine like 1), TGM2 (tissue transglutaminase 2), SPARC (secreted protein acidic rich in cystein), and three genes encoding for AZIN1 (antizyme inhibitor 1), ODC1 (ornithine decarboxylase 1) and SAT1 (spermidine/spermine N1-acetyltransferase), which are enzymes implicated in polyamine biosynthesis. The spatio-temporal expression patterns of SPARC and HMGN1 illustrate tissue and chromatin remodelling in the uterus at the termination of embryonic diapause. Having measured an increase in concentration of polyamines in the uterus at the resumption of blastocyst development, we have hypothetized that polyamines are implicated in the emergence of blastocysts from diapause. We inhibited polyamine biosynthesis in pregnant mink females during early blastocyst reactivation. The inhibition of polyamine biosynthesis through treatment with α-difluoromehtylornithine (DFMO) provoked a major reduction in cell proliferation in blastocysts at reactivation and a delay in the timing of implantation, but did not affect the success of reproduction. Similarly, we induced a reversible dormant state in cultured mink trophoblast cells traited with DFMO. To conclude, not only are results of this study a breakthrough in the understanding of the role of the uterus in stimulating at the emergence of blastocysts from embryonic diapause, but also, for the very first time, they indicate the existence of uterine factors, the polyamines, that are responsible for blastocysts reactivation.

L’oxaliplatine, anticancéreux utilisé pour le traitement du cancer colorectal, est responsable d’une neurotoxicité périphérique dose-limitante affectant une grande majorité de patients. La neurotoxicité de l’oxaliplatine se présente sous deux formes : une forme immédiate, se traduisant par des paresthésies transitoires, et une forme retardée et cumulative, caractérisée par l’apparition d’une neuropathie périphérique douloureuse fortement invalidante. A l’heure actuelle, la prise en charge des douleurs neuropathiques est souvent incomplète, principalement à cause du manque de traitements efficaces et bien tolérés. Dans ce contexte, il existe un réel besoin d’innovation thérapeutique pour améliorer le traitement de ces neuropathies, nécessitant au préalable une meilleure compréhension de leur physiopathologie. La première partie de ce travail porte sur l’évaluation de l’effet d’une alimentation sans polyamines sur l’apparition et la chronicisation de la neurotoxicité de l’oxaliplatine chez le rat. En effet, en modulant positivement la sous-unité NR2B des récepteurs NMDA, les polyamines alimentaires pourraient faciliter la sensibilisation douloureuse. Un régime sans polyamines a permis de prévenir l’hypersensibilité thermique et mécanique induite par l’oxaliplatine. Bien que ces symptômes nociceptifs ne soient pas associés à une augmentation de l’expression de la sous-unité NR2B au niveau spinal, l’ifenprodil (antagoniste NR2B spécifique) permet d’en diminuer l’intensité de manière dose-dépendante. Enfin, une étude métabolomique réalisée par spectroscopie RMN du proton a montré que le régime sans polyamines permettait de réguler la neurotransmission excitatrice (glutamate) au niveau de la corne dorsale de la moelle épinière des animaux, expliquant ainsi son effet antalgique. Dans un deuxième temps, nous nous sommes intéressés aux mécanismes supraspinaux impliqués dans la neuropathie chronique induite par l’oxaliplatine, à l’aide d’une approche métabolomique par 1 H-RMN HRMAS. Cette étude a révélé d’importantes modifications métaboliques cérébrales chez les animaux traités par oxaliplatine, notamment une augmentation de la choline dans le cortex insulaire postérieur corrélée de manière significative aux seuils douloureux. Une analyse transcriptomique et pharmacologique a permis de mettre en évidence une implication de la neurotransmission cholinergique dans cette structure. Le ciblage pharmacologique de cette neurotransmission pourrait représenter une stratégie potentiellement intéressante pour le développement de nouveaux traitements antalgiques. L’ensemble de ces résultats expérimentaux a permis l’identification de nouvelles pistes pour la compréhension et le traitement des douleurs neuropathiques chimio-induites. Dans une perspective de recherche translationnelle, ces deux approches précliniques sont en cours de transposition dans des protocoles de recherche clinique. Un essai clinique de phase II (NEUROXAPOL, NCT01775449) a débuté afin de confirmer l’intérêt d’un régime appauvri en polyamines chez des patients recevant une chimiothérapie à base d’oxaliplatine. Une seconde étude clinique (INSULOX) est actuellement en cours de préparation au CHU de Clermont-Ferrand afin de mesurer par IRM les concentrations en choline dans l’insula de patients souffrant de douleurs neuropathiques induites par oxaliplatine. / Oxaliplatin, an anticancer drug used for the treatment of colorectal cancer, is responsible for a dose-limiting peripheral neurotoxicity in the majority of treated patients. This neurotoxicity appears with two components: a rapid-onset acute neurotoxicity manifesting as transient paresthesias and cold-induced dysesthesias; and a late-onset cumulative neurotoxicity characterized by the development of a painful chronic neuropathy. To date, the management of chemotherapy- induced neuropathic pain is still challenging because of the lack of effective treatments. In this context, a better understanding of the pathophysiological mechanisms underlying this neurotoxicity could lead to the identification of new therapeutic targets. Firstly, we aimed to assess the preventive effect of a polyamine deficient diet on the development of oxaliplatin-induced acute neurotoxicity. Exogenous polyamines, by positively modulating spinal NR2B-containing NMDA receptors, could facilitate pain sensitization. This study has shown that a polyamine deficient diet for 7 days totally prevented oxaliplatin-induced acute cold and mechanical hypersensitivity in rats. Although we observed no change in spinal NR2B expression or phosphorylation, intrathecal ifenprodil (a specific NR2B antagonist) reduced oxaliplatin-induced allodynia in a dose-dependent manner. Finally, proton NMR spectroscopy- based metabolomic analysis has revealed a regulation of spinal glutamate neurotransmission as the most likely mechanism underlying the preventive effect of the diet. Secondly, the metabolic variations associated with oxaliplatin-induced chronic neuropathy were assessed at the supraspinal level using a 1 H-NMR HRMAS-based metabolomic approach. Among the neurochemical changes evidenced in this study, we observed a significant increase in choline within the posterior insular cortex, significantly correlated with the mechanical pain thresholds. A transcriptomic and pharmacological approach have revealed an implication of cholinergic neurotransmission in this brain area. Targeting the cholinergic system using centrally active muscarinic agents could represent an interesting strategy for the treatment of oxaliplatin- induced neuropathic pain. These experimental results led to the identification of new molecular targets for the comprehension and the treatment of chemotherapy-associated painful neuropathy. In a translational approach, these preclinical data will be extended to the clinical setting. A phase II clinical trial (NEUROXAPOL, NCT01775449) is undergoing to confirm the therapeutic interest of a polyamine free diet in patients receiving oxaliplatin. A second clinical project (INSULOX) aiming at assessing the choline concentrations in the insula of patients suffering from oxaliplatin-induced neuropathy is in preparation.

Acetylated polyamines, N 1 - and N 8 -acetylspermidine, are key intermediates in polyamine metabolism. Hexamethylenebisacetamide (HMBA) is a synthetic polyamine derivative known to induce in vitro biochemical and morphological differentiation of murine and human tumor cell lines. Deacetylation of HMBA and/or its metabolite N-acetyl-1,6-diaminohexane (NADAH) has been suggested to be catalyzed by N 8 -acetylspermidine deacetylase, a cytoplasmic enzyme involved in polyamine metabolism. The present investigation is focused on (1) the effect of N 1 - and N 8 -acetylspermidines, HMBA and NADAH on differentiation in Cloudman S91 melanoma cells, and (2) the effect of 7-[N-(3-aminopropyl)amino]heptan-2-one (APAH), a N 8 -acetylspermidine deacetylase inhibitor, on the effects of N 8 -acetylspermidine, HMBA, and NADAH on differentiation in Cloudman S91 melanoma cells. The biochemical signs of differentiation were measured as melanin content (absorbance at 475 nm) and tyrosinase activity (release of 3 H 2 O from 3 H-tyrosine) per μg protein. α-Melanocyte stimulating hormone (α-MSH) was used as a positive control. After 4 days of treatment, MSH at 100 nM raised the melanin to 293% of control (p < 0.05) and tyrosinase activity to 550% of control (p < 0.05). Spermidine did not produce any significant effect on these parameters in S91 cells. N 1 -acetylspermidine increased tyrosinase activity only at higher concentrations (100 and 1000 μM). However, 24-hour treatment of N 8 -acetylspermidine produced a dose dependent differentiation of S91 cells. At 10 −4 M, N 8 -acetylspermidine increased melanin by 85% and tyrosinase activity by more than 150% of control (p < 0.05). APAH alone had moderate effect on differentiation but potentiated and prolonged the effects produced by N 8 -acetylspermidine. HMBA decreased both melanin and tyrosinase activity in a dose dependent manner. After 4 days of treatment, 3 mM HMBA reduced melanin to 60% of control (p < 0.05) and tyrosinase activity to 4% of control (p < 0.05). NADAH is more active than HMBA. APAH was able to reduce the effects of HMBA (but not those of NADAH) on the parameters of differentiation. The results from the present study suggest that N 8 -acetylspermidine and HMBA have opposite effects on differentiation of S91 cells. The inability of APAH to counter NADAH-mediated decrease in tyrosinase activity suggests that APAH may be blocking the deacetylation of NADAH to an inactive metabolite.

Alcohol dependence is a major public health concern. Despite the FDA’s approval of multiple anti-relapse drugs, relapse rates remain unacceptably high. Furthermore, cognitive deficits among chronic drinkers are evident and are suggested to contribute to relapse risk. Current evidence suggests that several critical features of alcoholism and alcohol-associated neurodegeneration are mechanistically linked to glutamatergic actions; specifically, they appear positively affected by glutamatergic inhibition, particularly inhibition via polyamine modulation of a subpopulation of n-methyl-d-aspartate receptors. The current project was designed to evaluate the performance of two putative polyamine modulators (JR-220 and CP-101,606) in a variety of screens designed to identify the potential to reduce withdrawal severity, neurotoxicity and relapse risk. Screens included a complex organotypic screen designed to assess neuroprotective potential (Experiment 1), a simple behavioral screen designed to assess withdrawal severity (Experiment 2) as well as several more complex behavioral screens designed to examine cue-conditioning during withdrawal (Experiment 3), relapse behavior (Experiment 4), stress-associated consumption (Experiment 5) and binge-like consumption (Experiment 6). An additional open field experiment (Experiment 7) was conducted in order to address interpretational issues concerning activity in Experiments 2-6. Finally, as a first step in moving beyond simple screening, we expanded our binge screen to adhere more closely to an established, validated model of binge consumption (Experiment 8). While some interpretational issues were noted, taken together, the results from these experiments provide strong evidence for both drugs as potential pharmacotherapies for alcoholism and further implicate polyamines and NR2B subunits as critical mechanisms in ETOH consumption and withdrawal.

Kelpak®, a seaweed concentrate (SWC) prepared from the brown seaweed Ecklonia maxima (Osbeck) Papenfuss, improves overall plant mass and fruit yield in a variety of crops. The main active principals isolated from Kelpak® are cytokinins and auxins. Although these compounds are partly responsible for the growth promoting effect observed with Kelpak® application, they do not fully account for the complete effect of Kelpak® treatment. For this reason the focus has turned to polyamines (PAs) which are found in all cells of plants, animals and microorganisms, including eukaryotic algae. Polyamines also have growth promoting effects in plants. A study was carried out to investigate the PA levels in E. maxima and Kelpak® through a biennial cycle and to investigate if the PAs present in Kelpak® may have an effect on root growth, alleviating nutrient deficiency and the transport and accumulation of PAs in plants. To determine the amount of PA in the stipes, fronds and SWC prepared from E. maxima, samples were collected monthly over a two-year period (June 2009-June 2011). Extracts were benzoylated and quantified using a Varian HPLC. Putrescine concentrations ranged from 15.98-54.46 μg.g⁻¹, 6.01-40.46 μg.g⁻¹ and 50.66-220.49 μg.g⁻¹ DW in the stipe, fronds and SWC, respectively. Spermine concentrations ranged from 1.02-35.44 μg.g⁻¹, 1.05-26.92 μg.g⁻¹ and 7.28-118.52 μg.g⁻¹ DW in the stipe, fronds and SWC, respectively. Spermidine concentrations fell below the detection threshold. This is the first report of PAs being detected in a SWC. The seasonal pattern established for the stipe, frond and SWC followed the same trend over a biennial cycle. Polyamines accumulated in the seaweed tissue during periods of active growth and as a stress response elicited by rough wave action. This PA trend was similar to the cytokinin trend reported by MOONEY and VAN STADEN (1984b) for Sargassum heterophyllum which suggests that PAs play an important role in the hormone cascade during active growth. Routine monthly screening of Kelpak® carried out in the Research Centre for Plant Growth and Development indicated that Kelpak® consistently resulted in more rooting in the mung bean bioassay than the IBA control. The potential root promoting effect of PAs were investigated. Individually applied PAs did not increase rooting in the mung bean bioassay, but a synergistic relationship was observed between Put (10⁻³ M) and IBA (10⁻⁴ M). When applied together, rooting increased significantly above Put (10⁻³ M) and IBA (10⁻⁴ M) applied separately. The Put-auxin combination produced a similar number of roots to those treated with Kelpak®. It is possible that the PAs present in Kelpak® have a synergistic effect with auxins present in Kelpak® to promote root development and growth. Several physiological effects of Kelpak® and PAs on plant growth were investigated in a series of pot trials. Kelpak® significantly improved the growth of P- and K-deficient okra seedlings and masked the detrimental effects exerted by P- and K-deficiency. The application of PAs (10⁻⁴ M) significantly improved the seedling vigour index (SVI) of okra seedlings subjected to N-deficiency. The statistical difference was attributed to the N-containing growth regulators and polyamines being degraded and metabolized by the okra seedlings. Polyamine application did not alleviate P- and K-deficiency but increased root growth significantly in seedlings receiving an adequate supply of nutrients. It is likely that the additional PAs supported auxin-mediated root growth. A pot trial with okra plants was conducted to establish if the PAs in Kelpak®, applied as a soil drench or foliar application, are absorbed and translocated in a plant. Plants were also treated with Put, Spm, Spd to establish if PAs can be absorbed and translocated. Once the fruit had matured, plants were harvested and the endogenous PA content quantified by HPLC in the roots, stems and fruits. Applying PAs as a soil drench was not as effective as a foliar spray at increasing the PA content in the different plant parts. Kelpak® treatment (0.4%) did not contribute more PAs in any plant part. Spermidine concentrations were higher, in the various plant parts, than Put or Spm, irrespective of the mode of application. The application of Put, Spd and Spm increased Spd concentrations in the roots. Considering that Spd is the main PA produced in the roots and that exogenously applied PAs are readily converted to Spd, it seems evident that Spd is the preferred PA for long-distance transport in plants. The cytokinins and auxins in Kelpak® play an important role in stimulating growth in plants. It is, however, the totality of different compounds in Kelpak® that gives it its unique growth stimulating ability. Polyamines, occurring within the seaweed contribute to this activity, having an active role in root production and thus increased plant growth. / Thesis (M.Sc.)-University of KwaZulu-Natal, Pietermaritzburg, 2011.

Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.

La migration cellulaire est un processus complexe. Lors du développement, elle permet aux cellules de rejoindre leur destination finale, puis à l'âge adulte elle intervient dans de nombreux processus tels la réponse immunitaire ou le développement de pathologies.La migration est modulée par l'action de molécules d'adhérence. Nous nous sommes intéressés à la molécule NCAM (Neural Cellular Adhesion Molecule) dont les effets sont modulés par l'acide polysalique (PSA). Lors de précédentes études, il a été montré que le peptide mimétique de PSA-NCAM, PR-21 stimulait la migration issus de la zone sous-ventriculaire (SVZ).Nous avons synthétisés des analogues non-peptidiques de PR-21 en nous appuyant sur des analogies structurales. ces analogues ont été testés dans divers modèles de migration cellulaire : explants de SVZ et cellules C6 sur-exprimant PSA. Nous avons mis en évidence la présence de fonctions structurales clés dans la modulation de la migration cellulaire. / Cell migration is a complex process. During development, it contributes to cell reaching their final target. during adulthood, cell migration is involved in immune response or pathological processes.Migration is modulated by adhesion molecules. We concentrated on the Neural Cellular Adhesion Molecule (NCAM) which action is regulated by the post traductional addition of polysialic acid (PSA). PR-21 is a mimetic peptide of PSA-NCAM. In previous studies, PR-21 has been shown to stimulate in the migration of meuroblasts from sub-ventricular zone (SVZ) to the olfactory bulb.We designed non-peptidic analogues of PR-21 on the basis of structural analogies. these analogues were tested on various cell migration models : SVZ explants and C6 over-expressing PSA. We then established the need of key structural functions to modulate cell migration.

As leishmanioses constituem um complexo de doenças causadas por protozoários do gênero Leishmania. São transmitidas pela picada de fêmeas parasitadas do gênero Phlebotomus e/ou Lutzomyia. A leishmaniose é uma doença zoonótica que afeta mais de 12 milhões de pessoas no mundo, e constituem uma preocupação para a saúde pública. A arginase de Leishmania é a primeira enzima da via das poliaminas e constitui um importante alvo terapêutico devido ao seu papel ativo na sobrevivência do parasita no hospedeiro. Neste trabalho, 78 moléculas sintéticas e naturais de diferentes grupos químicos foram testadas com objetivo de determinar a sua capacidade de inibição da enzima arginase recombinante de Leishmania (L.) amazonensis (ARG-LA). Foram considerados inibidores da ARG-LA os compostos que apresentaram uma inibição &ge; 70% a 100 &micro;M. Os resultados revelaram 28,2 % de compostos com elevado potencial de inibição da ARG-LA, exibindo valores de IC50 na faixa micromolar. A cinética de inibição foi determinada pelo método de Dixon e Cornish-Bowden e revelou diferentes mecanismos de inibição enzimática. As moléculas sintéticas com potencial inibitório da ARG-LA correspondem aos ésteres e cinamidas biosintéticos, cinamidas derivados do ácido cafeico e pirazolopirimidinas. Além disso, foram testados 4 compostos naturais estruturalmente relacionados ao ácido caféico: piceatannol e 3 ácidos salvianólicos (A, B e D). Os resultados poderão servir de ponto de partida para o planejamento e síntese de novos fármacos para tratamento da leishmaniose, baseado na inibição da ARG-LA. / Leishmaniasis is a complex of diseases caused by Leishmania protozoa. They are transmitted by the bite of parasitized females of the Phlebotomus and/or Lutzomyia genus. Leishmaniasis is essentially a zoonotic disease, affecting more than 12 million people in the world and are a public health concern. Leishmania arginase is the first enzyme in the polyamine pathway and constitutes an important therapeutic target due to its active role in the parasite\'s survival in the host. In this work 78 compounds (synthetic and natural) of different chemical groups were tested to determine their ability to inhibit the recombinant Leishmania (L.) amazonensis arginase (LA-ARG). The IC50 and Ki were determined to the compounds that showed inhibition &ge; 70% at 100 &micro;M. The results indicated that 28.2% of the compounds have a high potential for LA-ARG inhibition, with IC50 values in the micromolar range and different enzymatic inhibition mechanisms. The main synthetic groups with the high inhibitory potential of the enzyme corresponding to the caffeic acid derivatives, pyrazolopyrimidines, and the natural compounds piceatannol and salvianolic acids. These results indicate a potential for the synthesis of new drugs for the treatment of leishmaniasis, based on parasite arginase inhibition.

<p>Amyotrophic lateral sclerosis (ALS) is characterized by a progressive loss of upper and lower motor neurons, resulting in muscle weakness and death from respiratory failure within 3-5 years after onset. The incidence is 1.5-2.7/100,000 inhabitants. 5-10% of all cases are hereditary. The aetiology of sporadic ALS is still unknown. </p><p>The only neuroprotective drug approved for the treatment of ALS is riluzole, a glutamate-antagonist, which has shown to improve survival. We evaluated if riluzole sales statistics can be used as a method for estimating the prevalence of ALS/motor neuron disease in Sweden. We found that this method, which is less time consuming than conventional methods, could be used as a crude marker for the prevalence. </p><p>In a longitudinal study of overall Quality of Life (QoL) in ALS we found that QoL changes only slightly over time despite disease progression. ALS does not necessarily result in a low QoL. </p><p>Growth factors are important for the survival of neurons. In ALS we found increased or normal levels of GDNF mRNA and BDNF mRNA in muscle biopsies, VEGF in serum and spinal cord and FGF-2 in serum and cerebrospinal fluid. There is thus no deficit of these growth factors although there may be a relative lack because of high demands of the motor neurons. Polyamines are small aliphatic molecules that are important for the function of cells. The level of the polyamines spermidine and spermine were increased in red blood cells in both patients with ALS and patients with Parkinson’s disease, suggesting that polyamines may have a role for the neurodegenerative process. Polyamines in spinal cord were of the same level in the patients with ALS and in controls, indicating a maintained regulation of polyamines at the end-stage of the disease.</p>

Warm-season turf species are becoming increasingly popular for putting green use in the transition zone. Ultradwarf bermudagrass (Cynodon dactylon (L.)  C. transvaalensis Burtt-Davy) is the prevalent warm-season putting green species, but seashore paspalum (Paspalum vaginatum Swartz) and ‘Diamond’ zoysiagrass [Zoysia matrella (L.) Merr.] may also be grown in the transition zone. Warm-season species are susceptible to winter injury and may require different management regimes than cool-season species. Therefore, the objectives of this research were to assess the impacts of various management practices on warm-season putting green species and characterize the physiological basis for differences in freeze tolerance of various warm-season putting green species. Field studies determined sampling procedures form thatch-mat depth and soil organic matter content of warm-season putting greens and assessed the impact of various management practices on different warm-season putting green species/varieties. The relative freeze tolerance of ‘Champion’ and ‘TifEagle’ ultradwarf bermudagrass cultivars, ‘SeaDwarf’ seashore paspalum, and Diamond zoysiagrass were determined, along with the accumulation of proline and polyamines during cold acclimation, in growth chamber studies. All species/varieties required different sampling numbers for determination of thatch-mat depth and soil organic matter. More sand was incorporated into the turf canopy and surface hardness was increased with brushing and vibratory rolling TifEagle putting greens after sand topdressing application than either treatment alone. Putting green management programs with lower mowing heights and increased mowing frequencies increased ball roll distance on a MiniVerde putting green without negatively affecting turf quality. Weekly vertical mowing + daily grooming on TifEagle reduced thatch depth and turfgrass quality, while increasing topdressing incorporation over either treatment alone. Diamond was the most freeze tolerant species/variety, followed by TifEagle, Champion, then SeaDwarf. Cold acclimation increased proline concentration for all species/varieties except SeaDwarf, but had inconsistent effects on polyamines. Spermidine and putrescine concentrations differed with species/variety, but were not correlated to freeze tolerance.